SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response

Philip Bland1, Harry Saville1, Patty T Wai1

  • 1The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.

Nature Genetics
|July 31, 2023
PubMed

Insights

SF3B1 mutations predict poor outcomes, but SF3B1 mutant cells are sensitive to PARP inhibitors (PARPi). This sensitivity stems from defective DNA repair, offering a new therapeutic strategy for SF3B1-mutant cancers.

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Genetics

Background:

  • SF3B1 hotspot mutations are linked to poor prognosis across various cancers.
  • These mutations cause widespread disruption of canonical RNA splicing.
  • Understanding the vulnerabilities of SF3B1-mutant cells is crucial for targeted therapies.

Purpose of the Study:

  • To identify therapeutic vulnerabilities in SF3B1-mutant cancer cells.
  • To investigate the mechanism underlying sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPi).
  • To evaluate the in vivo efficacy of PARPi in SF3B1-mutant cancer models.

Main Methods:

  • Synthetic lethal drug screens were employed to identify drugs targeting SF3B1 mutant (SF3B1MUT) cells.
  • Cellular responses to PARPi-induced replication stress were analyzed.
  • The role of cyclin-dependent kinase 2 interacting protein (CINP) and DNA damage response pathways (CHK1, ATM) was investigated.
  • In vivo studies utilized SF3B1MUT cancer models to assess PARPi efficacy.

Main Results:

  • SF3B1MUT cells exhibit selective sensitivity to PARPi, irrespective of mutation site or tumor origin.
  • These cells show a compromised response to PARPi-induced replication stress due to CINP downregulation.
  • This leads to increased replication origin firing, reduced pCHK1 (S317) induction, and failure to arrest the cell cycle.
  • CINP overexpression rescues these defects, and combination therapy with ATM and PARP inhibitors shows promise.
  • PARPi demonstrated significant antitumor effects and reduced metastasis in vivo.

Conclusions:

  • SF3B1 mutations create a vulnerability to PARPi by impairing DNA replication stress response.
  • Targeting this vulnerability with PARPi offers a potential therapeutic strategy for SF3B1MUT cancers.
  • Clinical trials of PARPi in biomarker-selected, homologous recombination proficient patients are warranted.

Related Concept Videos

Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
36.1K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.0K